Evidence map›Paper›PMID 38818376›Full record

ArticleFrontiers in pharmacology2024

Identification and validation of a platelet-related signature for predicting survival and drug sensitivity in multiple myeloma.

Zhili Lin, Quanqiang Wang, Ziwei Zheng, Bingxin Zhang, Shujuan Zhou, Dong Zheng, Zixing Chen, Sisi Zheng, Shuxia Zhu, Xinyi Zhang and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Zhili LinDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Quanqiang WangDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Ziwei ZhengDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Bingxin ZhangDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Shujuan ZhouDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Dong ZhengDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zixing ChenDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Sisi ZhengDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Shuxia ZhuDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xinyi ZhangDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Enqing LanDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Yu ZhangDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xuanru LinDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Qiang ZhuangDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Honglan QianDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xudong HuDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yan ZhuangDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhouxiang JinDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Songfu JiangDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yongyong MaDepartment of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biological functionsimmune microenvironmentsmultiple myelomaplateletprognostic gene signaturesensitivity to chemotherapeutic agents

Identifiers

PMID38818376
PMCPMC11137312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.